PCED1CP

Across TCGA pan-cancer cohorts, PCED1CP RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of PCED1CP’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where PCED1CP RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PCED1CP is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

LUSC, THCA, and LUAD are the cancer types where PCED1CP tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PCED1CP RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	+0.036	<.001	5	view →
THCA	Female	All	+0.093	<.001	3	view →
LUAD	All	All	+0.024	.024	1	view →
KIRC	All	II,III,IV	−0.012	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

PCED1CP–LUSC

Open the LUSC breakdown →